OTC - ACTIVE INGREDIENT SECTION
PHENAZOPYRIDINE HYDROCHLORIDE 97.5 MG
PHENAZOPYRIDINE HYDROCHLORIDE 97.5 MG
PHENAZOPYRIDINE HYDROCHLORIDE URINARY ANALGESIC
DO NOT EXCEED RECOMMENDED DOSAGE
ASK DOCTOR BEFORE USE
IF YOU HAVE KIDNEY DISEASE
ALLERGIES TO FOODS,PRESERVATIVES OR DYES
HAD A HYPERSENSITIVE REACTION TO PHENAZOPYRIDINE
WHEN USING THIS PRODUCT
STOMACH UPSET MAY OCCUR,TAKING THIS PRODUCT WITH OR AFTER MEALS MAY REDUCE STOMACH UPSET
YOUR URINE WILL BECOME REDDISH ORANGE IN COLOR.THIS IS NOT HARMFUL,BUT CARE SHOULD BE TAKEN TO
AVOID STAINING CLOTHING OR OTHER ITEMS.
STOP USE AND ASK A DOCTOR
IF YOUR SYMPTOMS LAST FOR MORE THAN 2 DAYS
YOU SUSPECT YOU ARE HAVING AN ADVERSE REACTION TO THE MEDICATION
ASK A HEALTH PROFESSIONAL BEFORE US
IN CASE OF OVERDOSE ,GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
Use; fast relief from urinary pain,burning,urgency and frequency associated with urinary tract infections.
Lactose, magnesium silicate, magnesium stearate, microcrystalline cellulose,
pharmaceutical glaze, and sodium starch glycolate.
Adults and Children 12 years of age and over; take 2 tablets 3 times daily with a full glass of water,with or after meals as needed.
Children under 12 years of age; consult a doctor.
Do not use for more than 2 days ( 12 tablets ) without consulting a Doctor.
NDC: 71335-1661-1: 6 Tablets in a BOTTLE
NDC: 71335-1661-2: 12 Tablets in a BOTTLE
NDC: 71335-1661-3: 36 Tablets in a BOTTLE
NDC: 71335-1661-4: 20 Tablets in a BOTTLE
NDC: 71335-1661-5: 10 Tablets in a BOTTLE
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71335-1661-1 | 2024-01-30 | C162847 | 48780-1 | 1030e364-f9f0-111a-e063-dadaa90a10e2 | Drug Facts |
| 71335-1661-2 | 2024-01-30 | C162847 | 48780-1 | 1030e364-f9f0-111a-e063-dadaa90a10e2 | Drug Facts |
| 71335-1661-3 | 2024-01-30 | C162847 | 48780-1 | 1030e364-f9f0-111a-e063-dadaa90a10e2 | Drug Facts |
| 71335-1661-4 | 2024-01-30 | C162847 | 48780-1 | 1030e364-f9f0-111a-e063-dadaa90a10e2 | Drug Facts |
| 71335-1661-5 | 2024-01-30 | C162847 | 48780-1 | 1030e364-f9f0-111a-e063-dadaa90a10e2 | Drug Facts |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-1661-1 | Sunmark Urinary Pain Relief Maximum Strength | 6 in 1 BOTTLE | TABLET | 6 | 2 | |
| 71335-1661-2 | Sunmark Urinary Pain Relief Maximum Strength | 12 in 1 BOTTLE | TABLET | 12 | 2 | |
| 71335-1661-3 | Sunmark Urinary Pain Relief Maximum Strength | 36 in 1 BOTTLE | TABLET | 36 | 2 | |
| 71335-1661-4 | Sunmark Urinary Pain Relief Maximum Strength | 20 in 1 BOTTLE | TABLET | 20 | 2 | |
| 71335-1661-5 | Sunmark Urinary Pain Relief Maximum Strength | 10 in 1 BOTTLE | TABLET | 10 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-1661 | SUNMARK URINARY PAIN RELIEF MAXIMUM STRENGTH (PHENAZOPYRIDINE HYDROCHLORIDE) TABLET [BRYANT RANCH PREPACK] | 2 | Legacy NDC, 5 package rows | 20220205_6f24b86c-ac61-4c4b-a7ba-86f875dd4d3e.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49348-941-01 | EA - Each | 49348-941 | b0f4efe2-281c-430c-abb6-3cd393b22b16 | 1 | 2022-06-06 |
| 49348-941-02 | EA - Each | 49348-941 | 46f92040-f39b-4580-a3e4-baf6ee672315 | 1 | 2012-07-24 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 71335-1661 | 71335-1661-1, 71335-1661-2, 71335-1661-3, 71335-1661-4, 71335-1661-5 |
| 49348-941 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PHENAZOPYRIDINE HYDROCHLORIDE | 0EWG668W17 | ACTIB |
| LACTOSE, UNSPECIFIED FORM | J2B2A4N98G | IACT |
| MAGNESIUM SILICATE | 9B9691B2N9 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6f24b86c-ac61-4c4b-a7ba-86f875dd4d3e | 6f24b86c-ac61-4c4b-a7ba-86f875dd4d3e | 2021-12-28 | Warnings | 6f24b86c-ac61-4c4b-a7ba-86f875dd4d3e 6f24b86c-ac61-4c4b-a7ba-86f875dd4d3e |
Adverse event summaries are temporarily unavailable. Other product information remains available.